Jubilant DDDS business offers integrated Services Platform across Target Validation, Discovery, Pre-Clinical and Clinical Development.

Drug Discovery and Development at Jubilant is driven by the passion to provide affordable drugs to the patients worldwide in the areas of unmet needs .Jubilant scientists collaborate across technology and therapeutic platforms to identify and validate novel small molecules and platforms that will enable first or best in class healthcare efforts of our collaborators. High quality innovation is supported by a robust and highly efficient R&D process that makes Jubilant the preferred partner for many global pharmaceutical and biotech companies.

With over 1000 highly skilled and experienced scientific and medical personal spread across Bengaluru and Noida in India, Europe and the US, the DDDS group leverages the capabilities in emerging markets for a global outcome, accelerating the global drug development efforts.

Jubilant Collaboration Strategy
Since its inception, Jubilant’s business model of providing functional services and shared risk partnerships across discovery and pre-clinical/clinical development portfolio has received wide acceptance and is demonstrated by the continuing long term and sustainable partnerships that the DDDS group has been able to enter.

Creative partnering efforts include:

• Risk sharing models across Discovery, preclinical and early phase development
• Collaborative Functional Outsourcing Programs
• Strategic Sourcing alignment- Build to suit
• Performance based/milestone based payment terms
• Accelerated asset development models
• Joint Ventures- strategic drug discovery and development

Jubilant’s services and integrated collaborations are designed to align with its collaborators’ therapeutic strategies across lead generation, preclinical and clinical development platforms. Jubilant provides functional and integrated solutions across the entire value chain of discovery and development to include:

	Drug Discovery and Pre-clinical Development Solutions
	Clinical Development Solutions

The Company offers an integrated and collaborative platform of drug discovery and development services to the global pharmaceutical industry. The business is integrated via three operating subsidiaries across the entire value chain of drug discovery and development - each with a range of capabilities across the value chain. The business covers a range of discovery services and shared risk collaborations with multiple global partners.

Jubilant Biosys Ltd., Bangalore, is an integrated discovery collaborator to major pharmaceutical and biotech companies, accelerating global discovery efforts across multiple therapeutic areas. Biosys engages in a range of functional discovery services and shared risk collaborations with multiple global partners.

Jubilant Chemsys focuses on providing medicinal chemistry services to the global pharmaceutical industry. Uniquely positioned to focus on medicinal chemistry aspects, it collaborates in all areas of medicinal chemistry that include design, synthesis, SAR support, scale-up,etc., accelerating Hit to lead optimization efforts within the global pharmaceutical industry.

Clinsys Clinical Research Inc. is uniquely distinguished as the only Indian clinical research organization with an integrated workforce across USA, Europe and India.  It provides collaborators global or regional clinical research solutions to include study management - phases I to IV, BA/BE/PK studies, clinical data management, Biostatistics.


Our Commitment:
We strive to provide high quality innovation and a global platform for accelerated drug discovery and development solutions, enabling our collaborators to provide affordable and high quality healthcare to patients worldwide.